Kang Hsu, Jr., MD is the Chief Medical Officer (CMO) of Canary Speech. He oversees Canary Speech’s clinical direction, supports product development, and works closely with strategic partners including Mayo Clinic, Microsoft, Samsung, LG NOVA, and major health systems. He also contributes to the company’s research efforts, collaborating with academic and industry partners to help advance the scientific development and clinical validation of voice biomarkers.
What sets vocal analysis apart is its simplicity and scale. Through a single 40‑second voice sample, multiple conditions can be screened simultaneously — no needles, no lab visits, and no physical presence required.